Pharma CEO/Top Executives Global Response to COVID-19 – Virtual Press Briefing – 19 March 2020 (Video)
Read moreTechnical Briefing: Launch Event of ‘Assessing the Value of Biopharmaceutical Innovation in Key Therapy Areas in Middle Income Countries’
Read more5th global Biopharma CEO / top execs virtual press briefing – COVID-19
Organized by IFPMA – representing the global innovative biopharmaceutical industry committed to addressing the novel coronavirus public health crisis.
Read moreIFPMA Director General Thomas Cueni Speech at the 2021 Fair Pricing Forum on 13 April 2021
Speech Thomas Cueni, Director General, IFPMA 13 April 2021 Good morning. “I have three main messages for you today: First, we hear you, and we are sensitive to the debate about cost and pricing. Second, we are seeing great transformative new treatments reaching patients, and we are making progress through new partnerships in reaching many...
Read more7th Global Biopharma CEO / top execs virtual press briefing – COVID-19
Organized by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) – representing the global innovative biopharmaceutical industry committed to addressing the novel coronavirus public health crisis.
Read more
How far we have come and how far we have yet to go
Against the backdrop of increasing concerns around Omicron, last week we convened a media briefing on the biopharmaceutical industry’s efforts over the past year since the first COVID-19 vaccine was administered.
Read moreCOVID-19: Finding a vaccine in record time
This article was originally published in French in AGEFI on March 3, 2020. Before it first emerged in December, the COVID-19 virus was unknown. Just a month later, the sharing of this new virus’s genome within the scientific community swiftly enabled researchers to set in train the initial stages of research and development (R&D) designed...
Read moreMomentum of COVID-19 vaccine manufacturing scale up sufficient for step change in distribution
Last week we convened another media briefing on the biopharmaceutical industry’s efforts to ramp up manufacturing capacity for COVID-19 vaccines, treatments and supplies. We were joined by CEOs and executives from Pfizer, Roche, Merck, Johnson & Johnson, whose 3 main take-aways I would like to share with you. The historic COVID-19 manufacturing scale up has...
Read moreGlobal Biopharma CEO/Top Executives COVID-19 Media Briefing / COVID-19 diagnostics, treatments and vaccines (Video)
Read moreVaccine experts recommend practical actions to support vaccine innovation and access around the world
Peer-reviewed article in Vaccine addresses the 4As of vaccine access – availability, affordability, adoption and alliances Paper’s recommendations offer insights on how to achieve the Decade of Vaccine’s goal of 90% global vaccine coverage by 2020. Increased vaccine awareness, predictable demand, and sustainable financing among 26 expert recommendations to support vaccine access and innovation A...
Read more